Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Monster Energy-Supported NASCAR Documentary “Blink of An Eye” Acquired by 1091 Media

Published

on

Reading Time: 5 minutes

Inspiring Life Story of NASCAR Icons Michael Waltrip and Dale
Earnhardt Sr. to Hit Theaters in Fall 2019

CORONA, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/NASCARDOCUMENTARY?src=hash” target=”_blank”gt;#NASCARDOCUMENTARYlt;/agt;–Prepare for the greatest sports story never told. As a long-time sponsor
of NASCAR, Monster Energy is proud to announce the acquisition of NASCAR
documentary Blink of An Eye by global commercial distribution
platform 1091 Media. Based on the true story of NASCAR icons Michael
Waltrip and Dale Earnhardt Sr., the documentary is produced and directed
by multi Emmy-winning filmmaker Paul Taublieb, known for Unchained:
The Untold Story of Freestyle Motocross
. Also serving as producers
are Monster Energy Vice President of Sports Marketing Mitch Covington,
who discovered the true story and brought it to Taublieb, next to Susan
Cooper and Pam Miller, and NASCAR’s Steve Phelps serving as an Executive
Producer.

Blink of An Eye was produced by Taublieb Films with support from
Monster Energy and in association with NASCAR. The film will premiere
with a private screening this coming Friday, May 24, at the NASCAR Hall
of Fame Theater in Charlotte, NC in front of an audience of NASCAR stars
and motorsports industry insiders, just prior to a major NASCAR race at
the Charlotte Motor Speedway. Audiences can look forward to seeing the
true-life saga at select theatres in New York and Los Angeles this fall,
which will make Blink of An Eye eligible for Academy Award
consideration. The documentary will be available On Demand, roll out to
+600 theatres nationwide and is expected to play at major film festivals.

Based on the New York Times bestselling book, Blink of An Eye focuses
on Michael Waltrip and his star-crossed friendship with iconic driver
Dale Earnhardt Sr. Over the course of 462 races, Waltrip failed to notch
a single win. He was on the longest losing streak in NASCAR history –
maybe in all professional sports – when he joined Earnhardt’s race team
for the 2001 Daytona 500. On the last lap of the Great American Race,
Waltrip held the lead with Earnhardt Jr. in second and “Sr.” in third.
Instead of making his trademark, ruthless charge to the front, Earnhardt
Sr. blocked the field of 40 cars to allow his friend to take his first
checkered flag. As fate would have it, Waltrip never had the opportunity
to celebrate with Earnhardt Sr., as the legend was killed on that last
lap in what was initially thought to be a minor crash. Later, Waltrip
would pay homage to “Sr.” on his return to Daytona in dramatic,
unexpected fashion.

Monster Energy senior executive Covington, who already produced and won
an Emmy for 2016’s Unchained with Taublieb, discovered the deeply
moving story of Waltrip and Earnhardt Sr. at a national sales meeting.
When he shared the story of perseverance and friendship, the entire room
was in tears. True to Monster Energy’s dedication to supporting athletes
past and present, it was no question that the brand would come onboard
as a title sponsor.

“It’s a story for the ages, and myself and the company are thrilled to
support and help bring it to life, and we’re all fortunate to have a
talent like Taublieb helming the project,” said Blink producer
and Monster Energy VP of Sports Marketing Covington.

Covington also wrote the theme song performed by Bobby Capps of 38
Special, which will be released as a single by Cali-Bama Records.

Brought to life in director Taublieb’s signature storytelling style, the
film features interviews with Michael Waltrip and Dale Earnhardt Jr.
along with Ty Norris, the former Executive Vice President of Motorsports
for Dale Earnhardt Inc., and NASCAR Hall of Famers Richard Petty and
Richard Childress, and includes a special audio cameo by country music
star, Trace Adkins.

Aware of the story’s wide appeal and emotional weight, Producer-Director
Taublieb said: “I’m humbled Michael Waltrip placed his trust in me to
tell his heartfelt and inspiring story in such intimate fashion, yet on
the large canvass of cars going 200 miles an hour. Blink of an Eye
is the most compelling sports story never told, and one that transcends
sports.”

Taublieb and his production company, Taublieb Films, are two-time Emmy
winners. They took the honors in 2014 for Best Sports Documentary Series
for Hawaiian: The Legend of Eddie Aikau, and in 2017 in the
Outstanding Long Documentary category for Unchained: The Untold Story
of Freestyle Motocross
, with Blink of an Eye Producer
Covington also winning an Emmy for his role as a Producer. Known for his
engaging visual storytelling and penchant for action sports, Taublieb
also directed surfing documentary The Monster Energy Big Wave Tow-in
Invitational
, recently premiered on ABC.

The deal was negotiated by 1091’s Danny Grant and Taublieb on behalf of
the filmmakers and Waltrip. Blink of an Eye was produced by
TAUBLIEB Films with support from Monster Energy and in association with
NASCAR, with NASCAR’s Steve Phelps also serving as an Executive Producer.

Blink of an Eye touches a much wider audience than NASCAR fans,
it is a story of perseverance and friendship that anyone can relate to,”
said Danny Grant, Senior Vice President of Film and Strategic
Partnerships. “Paul Taublieb does a fantastic, cinematic job with this
long untold story and we are excited to partner with Taublieb Films and
Monster Energy, along with the support of NASCAR, in bringing this film
to theaters and homes nation-wide.”

Blink of an Eye has also been acquired to be developed into a
dramatic feature film by legendary Hollywood producer Roger Birnbaum,
with whom Taublieb produced the hit film The Vow in 2014, which
grossed $200 million at the box office.

For more Monster Energy NASCAR racing and the 2019 Monster Energy NASCAR
Cup Series, visit www.monsterenergy.com
and follow Monster Energy on FacebookInstagram,
Twitter
for exclusive updates. For interview or photo requests contact Kim
Dresser
.

About Monster Energy

Based in Corona, California, Monster Energy is the leading marketer
and distributor of energy drinks and alternative beverages. Refusing to
acknowledge the traditional, Monster Energy supports the scene and
sport. Whether motocross, off-road, NASCAR, MMA, BMX, surf, snowboard,
ski, skateboard, or the rock and roll lifestyle, Monster Energy is a
brand that believes in authenticity and the core of what its sports,
athletes and musicians represent. More than a drink, it’s the way of
life lived by athletes, sports, bands, believers and fans.
See
more about Monster Energy including all of its drinks at
www.monsterenergy.com.

About Taublieb Films

TAUBLIEB Films is a two-time Emmy-winning production company led by
director/producer Paul Taublieb, and his wife and producing partner,
Susan Cooper.
Their work includes long-form feature
documentaries, including the ESPN 30 for 30 film, “Hawaiian: The Legend
of Eddie Aikau,” narrated by Academy Award-nominated actor Josh Brolin,
the theatrically released “FASTEST” about MotoGP racing, and the Netflix
documentary, “UNCHAINED: The Untold Story of Freestyle Motocross,” named
the best long form documentary of the year, also narrated by Brolin.
The
Malibu, CA-based company also produces short form content for brands
from Monster Energy to ESPN to Ferrari, including vial videos with
literally hundreds of millions views.
Taublieb and Cooper also
produced “The Vow,” starring Channing Tatum and Rachel McAdams (which
grossed $200 million worldwide), and award-winning dramas for networks
including Showtime, ABC and NBC.

About 1091 Media

1091 is a global commercial distribution platform for independent
film and television content creators, with an intent to invest in
technology and business intelligence.

1091 Media and its principals are growth investors who also lead
Dimensional Associates, the private equity arm of JDS Capital
Management, Inc. From 2003-2015, they owned a variety of media companies
through Dimensional, including The Orchard and Dimensional Music
Publishing. 1091’s content is available in more than 90 territories
worldwide and features 4,000 titles in its library, including the
leading action sports catalogue. 1091’s film releases include BIRDS OF
PASSAGE, WE THE ANIMALS, THE HERO, the Pedro Almodovar-produced EL
ANGEL, AMERICAN ANIMALS, and BPM (Beats Per Minute), THE DAWN WALL, as
well as Academy Award®-nominated documentaries CARTEL LAND and LIFE,
ANIMATED; and Taika Waititi’s HUNT FOR THE WILDERPEOPLE and WHAT WE DO
IN THE SHADOWS. Upcoming releases include Werner Herzog’s MEETING
GORBACHEV, HALSTON, THEM THAT FOLLOW and BEFORE YOU KNOW IT.
For
more information on 1091 Media, please visit,
www.1091media.com.

Contacts

Kim Dresser C: (949) 300-5546 E: [email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Cannabis

Right on Brands Announces Major Product Line Expansion via HONEY® Brands

Published

on

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania